• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. CRYOFLEX SURGICAL ABLATION PROBE; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING Back to Search Results
Model Number 60SF3
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Muscle Weakness/Atrophy (1967)
Date of Event 10/01/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
The patient had a concomitant surgical procedure of mitral valve repair through a minimally invasive procedure/ thoracotomy.During the same procedure on ((b)(6) 2024) a cryoflex probe powered by a cryoconsole, and a cardioblate lp clamp powered by a valleylab ft-10 generator were used.The left atrial appendage was successfully closed.Left pulmonary vein (lpv) was not performed as it was unable to be done due to the thoracotomy surgical approach and right pulmonary vein (rpv) conduction block was successfully achieved.On ((b)(6) 2024) the patient experienced a right hemidiaphragm elevation which was noted on the x-ray.The adverse event was deemed by the site as possibly related to the concomitant procedure but unlikely related to the study devices and study procedure.The patient's outcome status was recovering/resolving.Medtronic received additional information that the rationale for possibly relating the adverse event to the concomitant procedure is due to the opening of the right pericardium for access to the mitral valve.It is unlikely related to the study procedure as the same approach was used for mv.The rational for the adverse event being unlikely related to the cryo probe or the clamp is because the opening of the pericardium is the same as for the mitral valve exposure.Use of the devices should not cause more traction.
 
Additional Manufacturer Narrative
Additional information b5: medtronic received additional information that the patients outcome status was recovered on (24-march-2025).The patient was admitted for surgery to treat hemidiaphragm paralysis from (24-march-2025) to (25-march-2025).They recovered with no complications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYOFLEX SURGICAL ABLATION PROBE
Common Device Name
SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20795172
Report Number3008592544-2024-00107
Device Sequence Number20580514
Product Code OCL
UDI-Device Identifier00763000114626
UDI-Public00763000114626
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
K191526
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/16/2026
Device Model Number60SF3
Device Catalogue Number60SF3
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/11/2024
Supplement Date Received by Manufacturer12/09/2025
Initial Report FDA Received Date11/27/2024
Supplement Report FDA Received Date12/12/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/10/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age48 YR
Patient SexMale
Patient Weight99 KG
-
-